SCHEMBL2575428

SCHEMBL2575428

CC(C)Oc1ccc(OBOc2ccc(OC(C)C)c(F)c2)cc1F

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
P2RX3 P56373 4/20 0.36
TRPV3 Q8NET8 1/20 0.34
CSNK2A1 P68400 2/20 0.33
NAAA Q02083 1/20 0.33
FFAR4 Q5NUL3 6/20 0.33
MAOB P27338 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
ALDH1A3 P47895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9228799 0.84 KMT2A (0.31) MEN1MAPTKMT2AALDH1A1
SCHEMBL178391 0.81 CA12 (0.47) P2RX3MAOBMEN1MAPTKMT2A
SCHEMBL4010865 0.80 TDP1 (0.36) CSNK2A1FFAR4MAPTHPGDKMT2A
SCHEMBL23218 0.79 RAB9A (0.46) NAAAMEN1MAPTKMT2AL3MBTL1
SCHEMBL8417 0.79 ALDH1A1 (0.40) TRPV3FFAR4KMT2AALDH1A1ALDH1A3
SCHEMBL4012282 0.79 CSNK2A1 (0.51) CSNK2A1MEN1KMT2A
SCHEMBL2997372 0.77 KCNK3 (0.39) CSNK2A1
SCHEMBL19644906 0.75 CYP11B1 (0.43) TRPV3NAAAFFAR4MAOB
SCHEMBL177773 0.75 KDM1A (0.46) KCNQ3KCNQ2MAPTL3MBTL1
SCHEMBL5745812 0.75 MEN1 (0.50) KCNQ3KCNQ2P2RX3TRPV3CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2384327-A1 FUSED RING COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
WO-2010087515-A1 FUSED RING COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed